InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
40%
T+90 mean return
-5.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Scadden David, Director. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 9 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €48k. History available since 28 May 2021. The latest transaction was filed on 10 July 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
2,816 sharesCommon stockSEC:0001439222-26-000095:0
1,400 shares@ US$18.0929.7% of flowCommon stockSEC:0001439222-25-000084:0
1,400 shares@ US$40.0065.6% of flowCommon stockSEC:0001439222-25-000084:1
200 shares@ US$18.094.7% of flowCommon stockSEC:0001439222-24-000146:0
3,388 shares0Common stockSEC:0001439222-24-000079:0
4,975 shares0Common stockSEC:0001439222-23-000093:0
1,585 shares0Common stockSEC:0001439222-22-000053:0
1,686 shares0Common stockSEC:0001439222-21-000051
1,686 shares0Common stockSEC:0001439222-21-000051:0
9 of 9 declarations
About Scadden David
Scadden David serves as a Board Member at AGIOS PHARMACEUTICALS, INC. In this role, he contributes to governance and oversight of the company's activities, bringing his expertise in the pharmaceutical sector.
